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Several studies have shown that general and specific
cognitive dysfunction may be present during the early stages
of chronic kidney disease. These studies, however, were
conducted in elderly patients with comorbid conditions and
used a limited battery of cognitive tests. Here we determined
whether 40- to 54-year-old women in a population-based
cohort in Taiwan with moderate chronic kidney disease have
reduced cognitive performance. In total, 64 women with
moderate chronic kidney disease (estimated glomerular
filtration rate (eGFR) stage 3) were randomly matched by age
and education with 192 control individuals with eGFR stage 2
or better. All patients underwent the Rey Auditory-Verbal
Learning Test, visual memory, verbal fluency, Trail Making
Test, digit spans, and Hospital Anxiety and Depression Scale
neuropsychological tests. Women with moderate chronic
kidney disease had significantly worse performance in
delayed recalls and backward digit span than controls. Mixed
effects modeling showed that women with moderate chronic
kidney disease had reduced cognitive performance after
controlling for body mass index, menopausal status, and
psychosocial distress. Thus, in a population-based sample,
we found that midlife women have reduced cognitive
performance associated with early-stage chronic kidney
disease. If confirmed, routine cognition evaluation of patients
with mild chronic kidney disease may help identify this
problem earlier because mild cognitive impairment can
convert to dementia.
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Chronic kidney disease (CKD) is a worldwide public health
problem.1 The prevalence of CKD, which was approximately
11% in both the United States and Taiwan, has increased
dramatically during recent decades and may rise even
further in the future.2,3 The association between end-stage
renal disease and cognitive impairment has long been
well recognized.4,5 Because CKD is considered treatable and
preventable during its early stages,6 recent studies have
focused on patients with less advanced CKD. In one of these
studies, moderate renal impairment, which is defined by
elevated serum creatinine, was found to be associated with an
increased risk of dementia.7 Other studies have suggested that
general cognitive dysfunction or specific cognitive impair-
ments are already present during the early stages of CKD.8–12
However, most of these studies were conducted in elderly
cohorts or in patients with comorbid conditions.7–11 The
only exception was a recent study based on the Third
National Health and Nutrition Examination Survey, which
showed an association of moderate CKD with reduced
cognitive performance in a cohort of 20- to 59-year-old
adults.12 Nevertheless, this study was constrained by a limited
battery of cognitive tests.
Previous research suggested that either vascular cognitive
impairment or mixed vascular cognitive impairment and
Alzheimer’s disease appear to be more common in hemo-
dialysis patients than Alzheimer’s disease alone.4 Therefore,
the pathophysiology of cognitive impairment in aging dialysis
patients was considered an accelerated model of vascular
dementia.4 The most common impaired cognitive domains
in patients with advanced CKD were memory and executive
function.13 However, it is unclear which specific cognitive
domains are involved during the early stage of CKD.
Here, we conducted a study of cognitive function in
subjects with CKD in a population-based cohort of midlife
women.14 Our goals were to determine whether subjects with
CKD have cognitive deficits compared to their healthy
counterparts and whether these cognitive deficits are of the
same type as those previously reported by other studies. We
hypothesized that reduced cognitive performance, especially
executive dysfunction and memory impairment, were
associated with CKD even in the early stage.
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RESULTS
Study population
Of the 1622 subjects initially contacted, 88 (5.4%) refused to
participate, 37 (2.3%) missed the evaluation due to losing
their mail or moving, 9 (0.5%) were excluded because they
had severe mental retardation, psychosis, or severe hearing or
visual impairments, and 465 (28.7%) were excluded because
of incomplete data. After these exclusions, a total of 1023
women (63%) completed the study. The participants were
slightly younger than the nonparticipants in age (45.3±3.9
vs 46.0±4.2 years, Po0.001). The demographics, health-
related characteristics, and kidney function of all participants
are presented in Table 1. Sixty-three women (6.2%) had a
history of cardiovascular disease, including myocardial
infarction, coronary disease, heart failure, angina pectoris,
and arrhythmia. No subject reported having had a stroke.
The mean estimated glomerular filtration rate (eGFR) was
82.6±16.6ml/min per 1.73m2, and 64 women (6.3%) had
moderate CKD (eGFR: 30–59ml/min per 1.73m2). None
of the subjects had severe CKD (eGFRo30ml/min per
1.73m2). Twenty participants reported having had a renal
disease previously. Only 3 women among the 64 moderate
CKD subjects (4.7%) were aware that they had CKD.
Sixty-four participants with moderate CKD were matched
by their age and education group to 192 women without
CKD. Compared with the sampled subjects (N¼ 256), the
excluded participants (N¼ 767) were younger (44.6±3.6 vs
47.5±4.0 years, Po0.001) and had more years of education
(6.8±4.7 vs 5.1±4.5 years, Po0.001). The women with
moderate CKD exhibited lower eGFR values (54.2±6.8 vs
82.4±13.2, Po0.001), higher BUN levels (17.9±7.6 vs
15.0±3.8, Po0.001), higher creatinine levels (1.0±0.5 vs
0.8±0.1, P¼ 0.002), higher Hospital Anxiety and Depression
Scale (HADS) scores (8.8±5.6 vs 7.2±5.5, P¼ 0.04), and
lower body mass index (BMI) values (20.5±2.2 vs 24.9±3.5,
Po0.001) than the matched controls (Table 1). The two
groups had no differences in mean age, years of education, or
the proportions of individuals with diabetes mellitus,
hypertension, systolic blood pressure, serum total cholesterol,
serum total triglycerides, postmenopausal status, and lifestyle
variables.
Results of neuropsychological tests
Table 2 shows the cognitive performance results of the
women with moderate CKD and their matched controls. In
comparison with their matched controls, the women with
moderate CKD had worse performances in the Rey Auditory-
Verbal Learning Test (RAVLT) delayed recall and backward
digit span tests.
Table 1 | Characteristics of study subjects sorted by eGFR category
eGFR (ml/min per 1.73m2)
Total (n=1023) X60, n=192 30–59, n=64 Pa
Age (years) 45.3±3.9 47.5±4.0 47.6±4.1 0.87
Education (years) 6.4±4.7 5.1±4.5 6.5±4.7 0.99
eGFR (ml/min per 1.73m2) 82.6±16.6 82.4±13.2 54.2±6.8 o0.001
BMI (kg/m2) 24.1±3.6 24.9±3.5 20.5±2.2 o0.001
HADS score 7.9±5.5 7.2±5.5 8.8±5.6 0.04
Postmenopause (%) 21.6% 31.3% 35.9% 0.49
Diabetes mellitus (%) 5.2% 5.7% 4.7% 0.75
Hypertension (%) 8.1% 9.9% 6.3% 0.38
Systolic blood pressure (mmHg) 123.0±16.4 123.1±15.1 120.9±17.6 0.34
Diastolic blood pressure (mmHg) 77.8±10.3 77.6±9.0 76.2±8.9 0.31
BUN 14.7±3.9 15.0±3.8 17.9±7.6 o0.001
Creatinine 0.8±0.2 0.8±0.1 1.0±0.5 0.002
Serum total cholesterol (mmol/l) 192.6±36.6 197.9±37.7 199.8±38.2 0.72
Serum total triglyceride (mmol/l) 100.0±72.8 105.2±65.3 109.8±147.2 0.74
Smoke habit (%) 1.0% 1.0% 1.6% 0.74
Alcohol habit (%) 10.5% 9.9% 7.8% 0.62
Cardiovascular disease (%) 6.2% 6.8% 7.8% 0.79
Exercise (%): once a week or more 47.2% 42.2% 43.8% 0.88
Abbreviations: BMI, body mass index; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; HADS, Hospital Anxiety and Depression Scale.
aComparison of subjects of chronic kidney disease and their matched controls by t-test and w2-test.
Bold type indicates Po0.01.
Table 2 | Performance in neuropsychological tests of subjects
with CKD and control subjects
eGFR (ml/min per 1.73m2)
X60 (n=192)
controls
30–59 (n=64)
CKD Pa
RAVLT delayed recall 11.3±2.5 10.1±2.7 0.001
RAVLT learning score 47.9±9.5 49.5±9.6 0.23
RAVLT recognition score 13.9±1.5 14.0±1.6 0.54
Continuous recognition
paradigm of Kimura
69.5±6.0 68.9±7.1 0.82
Category verbal
fluency: animal
14.8±4.0 14.1±4.4 0.23
Trail Making Test A 69.3±36.8 81.6±56.6 0.16
Trail Making Test B 119.1±56.0 124.8±75.2 0.99
Forward digit span 9.7±2.8 9.6±2.9 0.84
Backward digit span 4.9±2.5 3.0±2.4 o0.001
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration
rate; RAVLT, Rey Auditory-Verbal Learning Test.
aP-value by Mann–Whitney U-test.
Bold type indicates Po0.01.
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The HADS score was associated with performance in
forward digit span according to the Spearman’s correlation
analysis (r¼ 0.09, P¼ 0.007); however, it was not associated
with the other cognitive measures. Postmenopausal subjects
displayed reduced cognitive performance in the RAVLT
delayed recall (10.4±2.9 vs 11.3±2.4, P¼ 0.01, Mann–Whit-
ney U-test), forward digit span (9.1±2.9 vs 10.0±2.8,
P¼ 0.03, Mann–Whitney U-test), and backward digit span
(3.9±2.4 vs 4.9±2.6, P¼ 0.02, Mann–Whitney U-test) tests
compared to premenopausal subjects. No relationship was
observed between the BMI values and the cognitive test
results.
A linear mixed effects model was carried out for each
cognitive domain to assess the significance of the effect of
moderate CKD diagnosis while matching for age and years
of education. The random effects variance estimates are
nonsignificant in each model. The results were significant
for the RAVLT delay recall (estimated mean±standard
error: moderate CKD group 10.1±0.3 vs matched control
11.3±0.2, P¼ 0.001), and backward digit span (estimated
mean±standard error: moderate CKD group 2.8±0.3 vs
matched control 4.9±0.2, Po0.001) domains and nonsigni-
ficant for the other neuropsychological tests. We again
observed significant relationships between moderate CKD
and cognitive performances as measured by the backward
digit span test (Po0.001) and the RAVLT delayed recall
(Po0.001) after adjusting for BMI values, HADS scores, and
postmenopausal status covariates.
Otherwise, serum creatinine was associated with poor
performances in Trail Making Test A (b coefficients¼ 0.26,
R2¼ 0.25, Po0.001), forward digit span (b coefficients¼
0.17, R2¼ 0.22, P¼ 0.003), and backward digit span
(b coefficients¼0.18, R2¼ 0.27, P¼ 0.002) after adjusting
for age, years of education, BMI values, HADS scores, and
postmenopausal status covariates.
DISCUSSION
We examined a cohort of midlife women in Taiwan with
moderate CKD. The vast majority of the women had not
been previously diagnosed with CKD. We observed that
subjects with moderate CKD performed worse on the
neuropsychological tests than did age- and education-
matched controls without CKD. The cognitive deficits were
most apparent in the domains of memory, attention, and
frontal executive function.
The results of our study showed that women with
moderate CKD had deficits in attention and working
memory, indicated by lower scores in the backward digit
span test, which is considered a sensitive measure of frontol-
executive cognitive changes.15 We also showed that women
with moderate CKD manifested poor performance in verbal
memory tasks as indicated by lower RAVLT delayed recall
scores. However, the subjects with moderate CKD performed
similar to controls in the RAVLT learning and recognition
tests, which measure nonexecutive retrieval functions. The
findings suggest that the poor performance on verbal
memory tasks in subjects with moderate CKD may be
caused by deficiencies in executive processes that support
memory retrieval.16 The results using serum creatinine as a
continuous independent variable suggest that women with
moderate CKD had poorer performance in attention, visual
tracking, and working memory, the involved cognitive
domains are similar to the finding using eGFR as indepen-
dent variable. The neuropsychological profiles of women with
moderate CKD in this study are similar to the profiles of
patients with vascular cognitive impairment.17 In studies of
patients with cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy, who are
generally young and therefore less likely to have concomitant
pathological changes associated with Alzheimer’s disease,
impairments in working memory and executive function
have been observed during the very early phase of the disease
before transient ischemic attacks or strokes.18 This pattern of
impairment has been suggested to represent the core of the
cognitive syndrome associated with small-vessel subcortical
ischemic diseases.19,20 Our findings support the theory that
ischemic cerebrovascular disease and the underlying vascular
pathology may have a role in the cognitive impairments of
patients with CKD.21
Most previous research on cognition and the risk of
dementia in patients with mild to moderate CKD had been
performed in elderly subjects. Furthermore, there have been
inconsistencies across these studies in terms of the specific
cognitive impairments that were associated with CKD.9–11
Although one study found that executive function, psycho-
motor skills, language, and attention were impaired in
postmenopausal, elderly women with CKD,10 another study
reported that visual recognition, visual memory, attention,
visual processing speed, and psychomotor performance were
negatively affected by CKD.11 A study of relatively healthy
adults, aged 20–59 years, showed that patients with moderate
CKD performed poorly in visual attention and visual recall
tasks, as assessed by the Symbol Digit Substitution Test and
the Serial Digit Learning Test, respectively.12 The results of
our study show that women with moderate CKD perform
poorly in verbal and working memory and executive function
tasks, which had not been previously assessed in individuals
of this age group.
Menopausal transition in midlife can be related to
decreases in some types of cognitive performance in
women.22 In this study, adjusting for menopausal status did
not affect the significance of the association between
moderate CKD and reduced cognitive performance. Prior
studies have found that a significant proportion of end-stage
renal disease and CKD patients suffer from depression,23
which may influence their cognitive performance.24 In our
study, the level of mood symptoms was higher in women
with moderate CKD than in the matched controls. Notwith-
standing, adjusting for the level of anxiety and depressive
symptoms measured by the HADS did not appreciably
change the association between moderate CKD and reduced
cognitive performance. In addition, our study observed no
Kidney International (2010) 78, 605–610 607
C-F Tsai et al.: CKD and cognitive function among midlife women o r ig ina l a r t i c l e
significant associations between cognitive performance and
BMI values despite the fact that women with moderate CKD
had lower BMI values than the controls.
The prevalence of moderate CKD in our cohort was 6.3%,
which is similar to the percentage reported for women in a
large prospective cohort that had a representative sample of
adults in Taiwan (6.4%).2 Furthermore, the low levels of
awareness (4.7%) of CKD status observed in our study were
consistent with a prior study in Taiwan that reported a high
prevalence and low awareness of CKD.25
The strength of the present data is that it studies a cohort
from a homogenous community, which allows us to assess a
group of subjects with early CKD that were not biased by
medical treatment. The neuropsychological tests in our study
assessed the five major cognitive domains commonly used to
define mild cognitive impairment: memory, attention,
language, visual-spatial, and executive function.26 There are
some potential limitations to our study. First, the cause of the
moderate CKD could not be determined by this cross-
sectional study. Herbal medicines or medications to treat
glomerulonephritis may be possible causes of CKD in our
sample. However, because we did not collect data regarding
medication usage, we could not ascertain whether they
caused CKD. Second, although we tried to adjust for most
known confounders, we could not control for all possible
confounding factors such as proteinuria, anemia, and
inflammation. Finally, all of our CKD subjects were
Taiwanese, midlife women, who presented the disease in a
moderate degree, which limits the generalizability of our
findings to other ethnic groups, men, and elderly women.
In summary, moderate CKD was significantly associated
with poorer cognitive performance in verbal memory,
attention, working memory, and executive function in a
population-based sample of women aged 40–54 years. These
findings suggested that cognitive dysfunction could develop
in the early stage of CKD even among midlife adults without
dominant medical comorbidities. Because mild cognitive
impairment may convert to dementia,26 physicians who take
care of people with CKD should consider evaluating their
cognition routinely to identify this problem earlier.
SUBJECTS AND METHODS
Study populations
The Kinmen Women-Health Investigation cohort is a
community-based study of midlife women in Taiwan that
has previously been described in detail.14 Kinmen is an
outlying island of Taiwan with Han Chinese inhabitants.
According to the registration record and data collected
during visits by research assistants, 1622 women aged 40–54
years were invited to participate in the study, who lived in the
two selected rural townships (Kin-Hu and Kin-Cheng). A
note regarding the study was published in local newspapers.
Approximately 1 week after the release of the announcement,
all targeted women were contacted by mail in an attempt to
enroll the eligible women. If a subject did not visit after three
phone calls, a research assistant would visit the subject’s
home. The institutional review board of the Taipei Veterans
General Hospital approved the study protocol.
Procedure
All subjects completed self-administered questionnaires in
the presence of trained interviewers to collect personal
information, including sociodemographic data, medical
histories, lifestyle factors, menopausal statuses, and mental
health conditions. The interviewers assisted subjects who
were illiterate or who did not understand questions. Serum
creatinine and blood urea nitrogen levels were measured
from serum at a single central laboratory using standard
methods. Blood pressure, body weight, and height were also
measured. The BMI was calculated as the body weight
divided by the body height squared (kg/m2) for each subject.
A 45-min battery of neuropsychological tests was performed
within 2 months of the blood test.
Creatinine assay and definition of CKD
Plasma creatinine (normal reference value 0.5–0.9mg/dl
(44–80 mmol/l) in women) was measured using Jaffe´’s kinetic
method with a sample blank on a Hitachi 717 automatic
analyzer (Boehringer Mannheim, Hitachi, Tokyo, Japan) and
human Creatinine Liquicolor. The method was calibrated
using the calibration for automatic systems, identification
number 759350 (Roche Diagnostics, Mannheim, Germany),
with reference creatinine concentrations (usually 3.62mg/dl
(319 mmol/l)) that were determined using gas chromatogra-
phy–mass spectrometry. The assayed chemistry control
(Lyphochek; Bio-Rad, Irvine, CA, USA) was used for quality
control to monitor the precision of the laboratory testing
procedures.
Because serum creatinine levels showed poor correspon-
dence to GFR in a prior Taiwanese study2 and may lead to
underdiagnoses of CKD,27 we used the abbreviated equation
from the Modification of Diet in Renal Disease Study to
estimate GFR (186 serum creatinine1.154 age0.203
0.742, where serum creatinine is measured in mg/dl).28
The application of the abbreviated Modification of Diet
in Renal Disease Study equation has been verified in
Chinese populations with CKD.29 CKD categorizations
were performed using the National Kidney Foundation,
USA (K-DOQI) guidelines.6 Moderate CKD, or CKD stage 3,
was defined by an eGFR value between 30 and 59ml/min
per 1.73m2.
Neuropsychological battery
Rey Auditory-Verbal Learning Test. The RAVLT is a
measure of verbal learning and memory.30 Three kinds of
raw scores are used to score the test. The learning score sums
the number of correct words that are immediately recalled
across the five learning trials, the delay recall score is the total
number of words reported correctly during the delayed recall,
and the recognition score is the total number of words
correctly recognized. The delayed recall score was used as an
index of verbal memory with executive load, whereas the
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learning and recognition scores were considered to reflect
nonexecutive retrieval processes.30
Forward and backward digit span subtest of the Wechsler
Adult Intelligence Scale-Revised. The digit span subtest of the
Wechsler Adult Intelligence Scale-Revised comprises two
different tests in which the patient is required to repeat digits
in forward (forward digit span) and reverse (backward digit
span) order. The forward digit span test is related to attention
and concentration, whereas the backward digit span test is a
measure of attention and working memory.31
Continuous recognition paradigm of Kimura. The contin-
uous recognition paradigm of Kimura involves the sequential
presentation of 70 nonsense figures.32 Four figures are
repeated seven times within the test. The subject is instructed
to answer ‘yes’ or ‘no’ as to whether a figure has been seen
previously or not. The raw score is the number of correctly
recognized repeated figures. The continuous recognition
paradigm of Kimura is a measure of visual recognition and
memory.
Trail Making Test, parts A and B. This Trail Making Test
involves connecting numbers (part A) or numbers alternating
with letters (part B) on a sheet of paper.33 The score is the
time to complete the task, measured in seconds. Part A
evaluates processing speed, part B tests executive function,
and both parts A and B evaluate visual-spatial scanning. The
higher the score is, the lower the performance was.
Verbal fluency. In the verbal fluency test, the subject
names as many animals as possible in 1min.34 The raw score
is the number of different animals correctly named with one
point for each correct response. This test measures language
and executive function.
Questionnaire about the demographics, lifestyle, and other
health factors
Women who had not menstruated within the previous
12 months were categorized as postmenopausal. Regular
daily smoking, weekly alcohol drinking, and weekly exercise
were recorded as lifestyle factors. We measured the degree of
psychological distress using the HADS, which was developed
for and validated in nonpsychiatric medical patients. Items in
the survey relating to mood disorders and physical illnesses
were eliminated.35 In this scale, high scores indicated poor
mental health.
The women also reported if they had any of the following
diseases: stroke, myocardial infarction, coronary disease,
heart failure, angina pectoris, arrhythmia, or hypertension.
Awareness of chronic renal disease was defined as having
moderate CKD and self-reporting having chronic renal
disease.
Statistical analysis
All statistical analyses were carried out using SPSS for
Windows version 15.0 (SPSS, Chicago, IL, USA). Demo-
graphics and other health-related variables were compared
between the moderate CKD and those without using t-tests
or w2-tests, as appropriate. All results are presented as the
mean±standard deviation (s.d.), unless otherwise noted.
Correlation analyses were performed using Spearman’s
correlations. The prevalence of CKD and the performance
in cognitive tests can be affected by age and educational
levels.2,36,37 To control these confounding factors, we used a
matched sample study. Women without CKD were defined as
control subjects. The individuals in the control group were
matched to cases by age (within 1 year) and years of
education (within 1 year). To reduce the measurement error
of the dependent variables, we randomly assigned three
controls to each woman with moderate CKD. The total
number of our selected control group was 192.
In the first step of data analysis, the means and standard
deviations of group performance on each neuropsychological
measure were calculated and compared by Mann–Whitney
U-test. In the second step, mixed effects models were used to
quantify associations between each neuropsychological mea-
sure (continuous outcomes) and case/control status. The
mixed effects model accounts for the correlation that exists
between the matched participants. To understand whether
differences in each cognitive function domain could be
attributed to differences between cases and controls, we
adjusted final models for potential confounding variables. To
avoid the eGFR might be a proxy for age, we also used serum
creatinine as a continuous variable to analyze its relationship
to cognitive function. To balance the type I and type II errors
in multiple comparisons, we defined a significant P-value as
being o0.01.
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